Rhinitis News and Research

RSS

Rhinitis, commonly known as a runny nose, is the medical term describing irritation and inflammation of some internal areas of the nose. The primary symptom of rhinitis is nasal dripping. It is caused by chronic or acute inflammation of the mucous membrane of the nose due to viruses, bacteria or irritants.

Comorbid atopic diseases affect prognosis of alopecia areata

Asthma, atopic dermatitis or Hashimoto's thyroiditis as concomitant diseases are risk factors for clinical features associated with a poor prognosis in circular hair loss, also known as alopecia areata (AA).

9 Jan 2025

Researchers uncover diverse asthma endotypes in youths using nasal transcriptomics

The study highlights T2-low and T17-high asthma endotypes in minoritized youths, offering insights for precision medicine and improved asthma management.

7 Jan 2025

Nasal fungi differ in people with allergies and asthma

This study identifies key differences in nasal fungi composition in asthma and allergy patients, offering insights into their role in airway disease dynamics.

19 Dec 2024

Study reveals nasal fungi diversity in allergy and asthma patients

Nearly a quarter of Portuguese adults have allergies that cause a runny nose. This respiratory disease, formally called allergic rhinitis and frequently associated with asthma, is a common problem around the world, and the upper airway is a key target for research into the underlying disease processes.

17 Dec 2024

Dupilumab improves symptoms of atopic dermatitis in children with co-existing conditions

Research at National Jewish Health and other institutions has shown that the biologic dupilumab improves signs and symptoms of moderate-to-severe atopic dermatitis (eczema) in young children whether or not they have another inflammatory condition, such as asthma, allergic rhinitis or food allergies.

5 Dec 2024

Adults with egg white allergy face significant quality of life challenges

Study reveals significant impairments in the quality of life for adults with hen's egg white allergy, highlighting the need for accurate food labeling and further research into effective treatments.

27 Nov 2024

Fine particulate matter linked to higher eczema risk

Researchers explore the association between exposure to fine particulate matter and the risk of eczema.

20 Nov 2024

Can olfactory loss predict disease? Study ties loss of smell to 139 health conditions

Olfactory dysfunction links to 139 conditions, with inflammation playing a key role in memory decline and cognitive issues. Olfactory enrichment shows promise.

1 Nov 2024

Climate change impacts pollen patterns and allergy sensitization in Chicago

People have heard for years that climate change is having a significant impact on plant vegetation patterns and influencing how pollen and mold produce.

25 Oct 2024

Key triggers for food allergies in children after organ transplants

Study reviews transplant-acquired food allergies, focusing on pediatric patients, particularly liver transplant recipients. It explores immune system dysfunction, immunosuppressive agents, and gut microbiota changes as contributors to the rise of food allergies after organ transplants.

23 Sep 2024

Long COVID significantly affects children for up to 36 months, vaccines offer crucial protection

Study reveals the significant and lasting impact of long COVID on children, emphasizing the protective role of vaccines and the increased risk of autoimmune disorders.

8 Sep 2024

Insilico Medicine partners with Inimmune to advance immunotherapeutic discovery

Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced that the company has achieved a groundbreaking collaboration with Inimmune, which will utilize Chemistry42, Insilico's proprietary generative artificial intelligence (AI) technology to accelerate the discovery and development of next-generation immunotherapeutics.

5 Sep 2024

Intranasal vaccine shows broad SARS-CoV-2 variant protection

Study demonstrates that a single-dose intranasal live-attenuated vaccine, CDO-7N-1, provides broad protection against SARS-CoV-2 and its variants by inducing potent immune responses, including neutralizing antibodies and T-cell activity, in animal models.

1 Sep 2024

How does the season of birth influence the risk of asthma and allergic rhinitis?

Finnish researchers report that season of birth likely impacts an individual’s future risk of developing airway allergy and related diseases.

20 Aug 2024

Finnish study links autumn and winter births to higher rates of asthma and allergic rhinitis

Being born in autumn or winter is associated with asthma and allergic rhinitis in Finland, a new registry-based study shows.

14 Aug 2024

Does type 1 diabetes affect taste and flavor recognition?

Type 1 diabetes patients show reduced taste and flavor perception, affecting food preferences and quality of life. This highlights the need for further research into the sensory changes in T1D.

7 Aug 2024

Study suggests limiting oral corticosteroid use to 90 days reduces adverse effects in atopic dermatitis patients

Researchers evaluated the association between long-term oral corticosteroid use and adverse events in adult patients with atopic dermatitis.

24 Jul 2024

Chronic Urticaria: Addressing unmet needs, emerging therapies, and advances in personalized treatment approaches

Emerging personalized treatment approaches for chronic urticari.

16 Jul 2024

“G900” gene enhancers may play a pivotal role in asthma-associated inflammation

Type-2 helper T (Th2) cells play intricate roles in the inflammatory response underlying asthma. Elevated levels of the protein GATA3 stimulate the maturation of these cells. Consequently, gene regions known as enhancers, which enhance the expression of the GATA3 gene, have been implicated in asthma-associated inflammation.

26 Jun 2024

Study links gene regulation to allergic airway inflammation

Asthma patients experience respiratory distress due to allergens like house dust mites or pollen. However, the various triggers for asthma share a common pathway involving the release of proteins called type-2 cytokines by Type-2 helper T (Th2) cells and group-2 innate lymphoid cells (ILC2s). Both Th2 and ILC2 require high amounts of GATA-binding protein 3 (GATA3) for their maturation.

25 Jun 2024